LINC00339: A Long Intergenic Non-Protein Coding RNA and Its Potential as a Drug Target

Target Name: LINC00339

NCBI ID: G29092

LINC00339

LINC00339: A Long Intergenic Non-Protein Coding RNA and Its Potential as a Drug Target

Introduction

LINC00339 is a long non-coding RNA (lncRNA) that has been identified in various studies as having potential involvement in various biological processes. Its unique feature is its ability to interact with protein-coding RNAs, which has led to its involvement in various cellular processes, including cell signaling, chromatin regulation, and tissue development.

In addition to its role in cellular processes, LINC00339 has also been shown to have potential as a drug target. Its unique structure and various interactions with protein-coding RNAs make it an attractive target for small molecules and other therapeutic agents.

The Structure of LINC00339

LINC00339 is a 24.8 kilobase (kb) RNA molecule that contains 19 exons and 18 introns. It has a unique feature in that it contains a double-stranded RNA structure that is formed by the joining of two separate single-stranded RNAs. This double- The stranded structure is composed of two monomers that are joined at their 5' ends and at their 3' ends, respectively.

The 5' end of LINC00339 contains a unique feature that is not found in many other RNA molecules. It contains a conserved domain that is known as the T-box, which is a common structural motif found in T-cell receptor (TCR) genes . This conserved domain is responsible for the interaction of LINC00339 with protein-coding RNAs.

The 3' end of LINC00339 also contains a unique feature that is not found in many other RNA molecules. It contains a conserved domain that is known as the A-box, which is a common structural motif found in neurotransmitter receptors. This conserved domain is responsible for the interaction of LINC00339 with protein-coding RNAs.

The Interaction of LINC00339 with Protein-Coding RNAs

LINC00339 has been shown to interact with various protein-coding RNAs. One of the most well-studied interactions of LINC00339 is its interaction with the protein-coding RNA BCL2. BCL2 is a well-known gene that has been shown to play a role in Various cellular processes, including cell growth, apoptosis, and DNA damage repair.

Studies have shown that LINC00339 interacts with BCL2 through its conserved T-box and A-box domains. These interactions are thought to play a role in the regulation of BCL2 function and the regulation of various cellular processes.

In addition to its interaction with BCL2, LINC00339 has also been shown to interact with several other protein-coding RNAs, including NF-kappa-B, AP-1, and SMAD3. These interactions are thought to play a role in the regulation of various cellular processes , including cell signaling, chromatin regulation, and tissue development.

The Potential as a Drug Target

The unique structure and interactions of LINC00339 make it an attractive target for small molecules and other therapeutic agents. Its interaction with protein-coding RNAs and its conserved domains, such as the T-box and A-box, make it likely to be responsive to various small molecules.

In addition to its potential as a drug target, LINC00339 has also been shown to play a role in the regulation of various cellular processes. Its interaction with BCL2, a well-known gene that has been shown to play a role in various cellular processes, suggests that it may be involved in the regulation of cell

Protein Name: Long Intergenic Non-protein Coding RNA 339

The "LINC00339 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LINC00339 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets